Literature DB >> 35372902

Should My Patient Accept a Kidney from a Hepatitis C Virus-Infected Donor?

Javier Pagan1, Marco Ladino1,2, David Roth1.   

Abstract

Entities:  

Keywords:  Antiviral Agents; Hepatitis C virus; Tissue Donors; Transplantation; kidney transplantation

Mesh：

Year:  2020        PMID： 35372902      PMCID： PMC8809094          DOI： 10.34067/KID.0001012019

Source DB:  PubMed          Journal:  Kidney360        ISSN： 2641-7650


× No keyword cloud information.
  23 in total

1.  Transplanting Hepatitis C-Positive Kidneys.

Authors:  Peter P Reese; Peter L Abt; Emily A Blumberg; David S Goldberg
Journal:  N Engl J Med       Date:  2015-07-23       Impact factor: 91.245

2.  Fibrosing cholestatic hepatitis after kidney transplantation from HCV-viremic donors to HCV-negative recipients: A unique complication in the DAA era.

Authors:  Nikhil Kapila; Kawtar Al-Khalloufi; Pablo A Bejarano; Jason M Vanatta; Xaralambos B Zervos
Journal:  Am J Transplant       Date:  2019-09-18       Impact factor: 8.086

3.  Safety and Efficacy of Treatment of Hepatitis C in Kidney Transplant Recipients With Directly Acting Antiviral Agents.

Authors:  Michelle Lubetzky; Soohwan Chun; Andrew Joelson; Maria Coco; Layla Kamal; Maria Ajaimy; Paul Gaglio; Enver Akalin; Graciella De Boccardo
Journal:  Transplantation       Date:  2017-07       Impact factor: 4.939

4.  Pros and Cons: Usage of organs from donors infected with hepatitis C virus - Revision in the direct-acting antiviral era.

Authors:  Audrey Coilly; Didier Samuel
Journal:  J Hepatol       Date:  2015-09-12       Impact factor: 25.083

Review 5.  Treating hepatitis C virus in dialysis patients: How, when, and why?

Authors:  Javier Pagan; Marco Ladino; David Roth
Journal:  Semin Dial       Date:  2018-11-26       Impact factor: 3.455

6.  De novo membranoproliferative glomerulonephritis in hepatitis C virus-infected renal allograft recipients.

Authors:  D Roth; R Cirocco; K Zucker; P Ruiz; A Viciana; G Burke; M Carreno; V Esquenazi; J Miller
Journal:  Transplantation       Date:  1995-06-27       Impact factor: 4.939

Review 7.  Hepatitis C Virus Infection in Chronic Kidney Disease.

Authors:  Marco Ladino; Fernando Pedraza; David Roth
Journal:  J Am Soc Nephrol       Date:  2016-04-19       Impact factor: 10.121

Review 8.  Hepatitis C virus infection in haemodialysis and kidney transplant patients.

Authors:  Seema Baid-Agrawal; Manuel Pascual; Darius Moradpour; Ulrich Frei; Nina Tolkoff-Rubin
Journal:  Rev Med Virol       Date:  2008 Mar-Apr       Impact factor: 6.989

9.  Successful Treatment of Hepatitis C in Renal Transplant Recipients With Direct-Acting Antiviral Agents.

Authors:  D Sawinski; N Kaur; A Ajeti; J Trofe-Clark; M Lim; M Bleicher; S Goral; K A Forde; R D Bloom
Journal:  Am J Transplant       Date:  2016-02-05       Impact factor: 8.086

10.  Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study.

Authors:  David Roth; David R Nelson; Annette Bruchfeld; AnnMarie Liapakis; Marcelo Silva; Howard Monsour; Paul Martin; Stanislas Pol; Maria-Carlota Londoño; Tarek Hassanein; Philippe J Zamor; Eli Zuckerman; Shuyan Wan; Beth Jackson; Bach-Yen Nguyen; Michael Robertson; Eliav Barr; Janice Wahl; Wayne Greaves
Journal:  Lancet       Date:  2015-10-05       Impact factor: 202.731
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.